Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC

NCT02492568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: pembrolizumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]